<?xml version="1.0" encoding="UTF-8"?>
<p id="Par76">Of the 76 clinicians (
 <italic>n</italic> = 76/115, 66%) from 30 European countries who responded to the survey, 29% reported using CMGs produced by US-based, 27% by national, 23% by local and 14% by European organisations. There were no national CMGs identified from those countries where respondents reported using international CMGs.
</p>
